ArticlePDF Available

Abstract and Figures

Chronic kidney disease is rising worldwide in parallel to that of non-communicable disease. Kidney transplantation is the gold standard of care. We aim to provide a model for Oman transplantation and its health system This is a situational analysis of the incidence and prevalence of end-stage kidney disease in Oman. Also, we examined the transplantation trends and the health system. We review the local transplantation and the commercial transplantation. Further, we reviewed few transplantation models to provide some insight into Oman model of transplantation.
Content may be subject to copyright.
Research Article
Trends in Transplantation
Trends in Transplant, 2020 doi: 10.15761/TiT.1000281 Volume 13: 1-7
ISSN: 1887-455X
Transplantation Model- Analytical Review: A Strategic
Proposal and Moral Obligation
Issa Al Salmi1*, Fatma Al Rahbi1, Ehab Mohammed1, Dawood Al Riyami2, Salima Al Alawi1 and Suad Hannawi3
1The Renal Medicine Department, the Royal Hospital, Muscat, Oman
2Nephrology Unit, Medicine Department, SQUH, Muscat, Oman
3The Medicine Department, MOHAP, Dubai, UAE
Abstract
Chronic kidney disease is rising worldwide in parallel to that of non-communicable disease. Kidney transplantation is the gold standard of care. We aim to provide
a model for Oman transplantation and its health system
is is a situational analysis of the incidence and prevalence of end-stage kidney disease in Oman. Also, we examined the transplantation trends and the health
system. We review the local transplantation and the commercial transplantation. Further, we reviewed few transplantation models to provide some insight into Oman
model of transplantation.
Oman facing a tsunami of end-stage kidney disease. Its one-o a few countries around the world where almost people with functioning kidney transplant equal
number on hemodialysis. However, majority of kidney transplantation were procured commercially outside the country. Upon their return home, these patients
receive their full management at tertiary hospital without any further diculties or issues of concern.
Oman health system needs to further strengthen its health services. is requires a strong political lead with full logistic and nancial incentives. Both citizens and
residents need to receive the necessary health requirements for ESKD. Transplantation, both deceased and living donation, need to be improved with strong tie with
World Health Organization and Istanbul Declaration rules adherence.
*Correspondence to: Issa Al Salmi, MD, BA, BAO, Bch, MB (Trinity College),
FRCPI, MRCP (UK), FRCP, MIPH, PhD (AUS), FASN (USA), e Royal
Hospital, 23 July Street, P O Box 1331, code 111, Muscat, Oman, Tel: 968
92709000; Fax: 968 245 99966; ORCID: 0000-0002-3443-5972; Research ID:
J-4622-2014; E -mail: isa@ausdoctors.net
Key words: transplantation, health system, medical tourism, chronic kidney
disease, Oman
Received: September 14, 2020; Accepted: October 12, 2020; Published: October
15, 2020
Introduction
Oman is the second largest country in the South East of Arabian
Peninsula that has a total population of 3, 831 553. e burden of non-
communicable diseases including chronic kidney disease is a serious
health care issue in Oman. Almost 40,000 persons aged 40 years, or
more were screened for chronic kidney disease (CKD) in a preliminary
survey performed in 2009 throughout Oman [1-3]. Of the individuals
screened, 0.9% had severe renal failure, with an estimated glomerular
ltration rate of less than 30 ml/min/1.73 m2; 9% had moderate renal
failure with estimated glomerular ltration rates between 30 and
59 ml/min/1.73 m2; and 29% had mild renal failure with estimated
glomerular ltration rates of 60 to 90 ml/min/1.73 m2 [3]. ere is a
gradual increase in the prevalence of end-stage kidney disease (ESKD)
and outpatient’s morbidity caused by CKD in Oman [3].
All citizens have easy and free access to health services all over the
country [2,3]. At the beginning, the number of patients with ESKD
was very small, and they were sent to India for dialysis and lived there
for the rest of their lives. In 1983, those patients who were still living
in India were brought back to Oman when the rst dialysis unit was
established. e number of patients was small, and a single dialysis unit
was enough for all patients across the country. In addition, all services
were provided for them, including transportation [2,3]. However, with
the increasing number of patients and rising prevalence of citizens
with ESKD, Ministry of Health built new units to cope with the
rising number of patients. e location of new units was built in close
proximity to the majority of patients in each area [3].
Statistics of the ESKD incidence showed that during 1983,
there were 34 patients, and in 2015 there were 230 patients per total
population. e incidence reported by the end of the year 2018 was 350
patients per country per annum. All 24 hemodialysis centres are fully
operated 24 hours a day and many patients are only on twice weekly
dialysis sessions [3]. Oman ESKD patients are very young compared
to those in Europe or North America. DOPPS study has revealed that
these patients despite being young have developed major morbidity
and mortality. Hence, improvement of kidney transplant service is
demanded.
If this high CKD incidence is to be followed by a rapid rate of
progression, with short duration in each stage of CKD, it is probable
that we are seeing only the tip of the iceberg of ESKD with RRT. e
nature of the relationship between CKD and ESKD is multifaceted,
and many risk factors interact in a complex way that may ultimately
determine its incidence and prevalence and the progression toward
Issa Al Salmi (2020) Transplantation Model- Analytical Review: A Strategic Proposal and Moral Obligation
Volume 13: 2-7
Trends in Transplant, 2020 doi: 10.15761/TiT.1000281
ESKD across various populations. However, based on our data showing
the continuing large increase in the prevalence of treated ESKD in
Oman, the picture looks grim, with a high prevalence of CKD at the
present time [1-3].
We noticed an uncommon observation that the number of ESKD
patients living with a kidney transplant is almost equal to the number
of patients treated with hemodialysis. In Oman, which has exclusively
a living-related kidney transplant donation program, this program
contributes 22.7% of the kidney transplantations for all the ESKD
patients living with a kidney transplant within Oman. is has been
the result of commercial transplantation from various developing
countries. Deceased donor programs contributed to only 1.3% of
total transplanted cases in Oman. However, 76% of kidney transplant
cases are commercial transplantations that are being done abroad.
is illegal pathway has led to an almost equal number of transplant
cases and hemodialysis cases in the country. is has been driven by
various socioeconomic and cultural beliefs. is manuscript aims to
review several transplantation models and provide an insight for Oman
to overcome its organ shortage and transplantation need and curtail
transplant tourism [3-5].
Method
We reviewed Saudi Arabia, Israel, Iran, Pakistan and United State
transplantation system or model and their history. We elaborated the
situation of the transplantation program. en, we discuss the issues
and concerns of transplantations in Oman. Later on, we provided
an insight into taken to achieve a reasonable success. At the end, we
proposed a comprehensive transplantation model program for Oman
to improve the care of people inside the country and curtail the
transplant tourism from neighboring countries.
Organ Transplant Models- worldwide
Saudi Arabia Model
In Saudi Arabia (SA), transplant centers are performing both
living related and deceased kidney transplantation. However, living-
unrelated kidney transplantations is prohibited.
e rst Living related kidney transplant was done in 1979 [6], and
the rst deceased kidney transplant was in 1981 which started as Euro-
transplant. During this period of time, SA hospitals were receiving
kidneys from Europe where it was been rejected due to various
reasons such as anatomical abnormalities, prolong ischemia time or
unacceptability for the transplant. So, these kidneys were suboptimal
in their functions. e nephrologists worked as coordinator to nd the
recipients for those kidneys.
During the same period, they worked very hard to obtain religious
approval (Fatwa) [6], for cadaveric transplant which was approved
in1982 [6].
For cadaveric transplantations, national kidney foundation was
established in 1985. One of its main function was to establish the
transplant waiting list where all patients with ESKD were registered
and to organize the kidneys from cadaveric kidney transplantation.
Later, the foundation was renamed as Saudi Center of Organ
Transplantations (SCOT) when other organs like heart, lungs, livers
and cornea were utilized for transplantations [6,7].
ere were regional coordination oces in all major hospitals
throughout SA, which are working under SCOT. e function of these
oces is to identify cases with brain death from emergency rooms and
ICUs and obtain consent for donation [6,7].
e kidney allocated to national patients whenever a suitable
patient is available. If there are no suitable national patients, and aer
obtaining consent, the kidney may be transplanted to a non- national
patient with priority for residents followed by visitors. Moreover,
kidneys could be exchanged with other countries according to an
agreement established between the SCOT and similar institutions in
other Gulf countries [8].
It was noted that the numbers of identied brain-dead patients are
more than the consent obtained from families. Patients are going for
commercial kidney transplantations and come with complications that
needed to be managed. For which, media and religious leaders through
SCOT play a major role in educating the society and make them aware
about the diseased kidney program and hence, the kidney donation
increased since 1990 and onward [6,7]. In addition, the unlimited
governmental support of all transplantation activities, e.g., cadaveric
donor’s families are oered nancial support and free transportation of
the donor’s body to their country of origin in the case of expatriates [6,7].
For the living kidney transplantations, the donor should be
blood- related or must be the breast-feeding mother and that must be
conrmed by ocial specialized institutions. And emotionally related
and non-directed non-commercial donation can be accepted. SCOT
is a distinguished model for the region and especially the GCC, where
there are very close similarities between such countries such as patients
demography and health systems [8-10].
United State Model
Living related, living unrelated and diseased kidney transplantations
are conducted in USA to help patients with ESKD.
ere are multiple kidney transplantations centers in USA and
each center has its own criteria for kidney transplantations. Moreover,
not all centers doing all the type of transplantations [11-13]. It is the
duty of the patient to choose the center of kidney transplantations for
which patient should consider the following:
1- Insurance and cost
2- Location of the transplant center to ease to access
3- If patient has living donor, he needs to make sure that center is
doing Living kidney transplant.
4- Centers is doing kidney paired exchange program.
In 1950s, each center was working alone and if the kidneys from
cadaver transplant does not match for any patient from that center,
it will be discarded. Hence, United Network for organ sharing
(UNOS) was established in 1984 and all patients who are waiting for
kidney transplantations will be registered and diseased kidneys will be
organized and distributed equally among all centers.
Patients can be register in the waiting list once they started to have
eGFR <20 and on dialysis. Initially the program was accepting diseased
kidney and living related kidney transplantation. But between 1998
and 2008, it was noted that the numbers of patients in waiting list are
increasing in comparison to available kidney donors and there was a
signicant reduction in the number of living related donors since 2003
[14,15]. Also, aging transplant candidate population and concurrent
medical unsuitability of prospective donors as well as nancial
disincentives [12,15,16]. Moreover, the concerns of the nephrologists
that most donors lost follow- up aer 1-year post-kidney donation.
Because the outcome of living kidney transplantation was better
than deceased donor, the following actions were taken:
Issa Al Salmi (2020) Transplantation Model- Analytical Review: A Strategic Proposal and Moral Obligation
Volume 13: 3-7
Trends in Transplant, 2020 doi: 10.15761/TiT.1000281
1. e establishment of kidney paired donation (KPD) programs, in
this system living donors who are incompatible with their intended
recipients either because of ABO incompatibility or because of
sensitization (leading to a positive cross-match) participate in a
“donor pool,” resulting in an expanded availability of organs.
2. Permission of a non-directed live kidney donor (sometimes referred
to as altruistic donors). ese individuals oer to donate a kidney,
but do not identify the specic recipient [2-4].
In regards of increasing the diseased kidneys, it was thought to
increase diseased transplantation by using donors at extremes of age,
double kidney transplants from marginal donors and extended-criteria
donors [12,14,17,18].
Israel Transplantation Model
Kidney transplantation has been available in Israel since the mid
of 1960’s. e rst two kidney transplants, one from a living related
donor and the second from a deceased donor, were performed at
approximately the same time at two dierent hospitals. Aerwards,
kidney transplantation began to be performed in several hospitals
throughout the country, but the overall numbers remained small [19].
In 1994, e National Transplant Center was established as an
Israeli governmental organization. e objectives of the organization
were to: promote organ transplantation, maintain a central list of
potential transplant candidates, and select recipients as organs become
available as well as to provide guidelines for various functions, such as
selection of patients and collection of data.
Despite of these eorts, the number of kidney transplantation
remained less than 150 per year in the early 2005. As a result of this,
many Israelis with kidney failure travelled to other countries for kidney
transplantation. Organ tracking led to sever legislation and sanctions
based on the adoption of Istanbul declaration [20].
In 2008, e Israel Knesset enacted 2 laws [21,22], the 1st dened
brain death and provided the criteria for diagnosis brain death [23], the
2nd law, the transplantation law, dened the conditions for performing
transplants using deceased and live donors in Israel [24,25].
By these laws’ direct payment to donors and reagents were regarded
as illegal, remuneration for loss of income was permitted and regulated
and the regulations regarding the requirements for the use of organs
from living donors were published [24,25].
e attitude of Jewish religious leaders regarding organ
transplantation: Historically, many, but not all, rabbinic authorities
rejected the use of organs from deceased donors for transplantation
[23,26,27]. e main objection was related to the denition of brain
death, which is not considered acceptable to many rabbinical authorities,
as opposed to cardiac death, which was universally accepted [19,22,25].
Matnat Chaim encourages live kidney donation among Orthodox
Jews in Israel: A non- prot organization, Matnat Chaim (“Gi of life”
in Hebrew), a faith-based initiative, has emerged as a major force for
organizing Living Donor Kidney Transplantation mainly by facilitating
altruistic living un-related transplantation with an emphasis on donors
from the Orthodox Jewish community through:
A- Increase the awareness in the media, both traditional media, such as
newspapers, magazines, radio and television, as well as new media,
such as internet and social media sites, especially Facebook.
B- e organization produces magazine supplements that disseminate
stories describing the life and suering of dialysis patients, as well as
inspiring stories of kidney donors.
C- Group meeting.
e organization helps donors navigate the health system and refers
them to the Physician with particular experience in advising kidney donors.
e organization does not interfere with matching or donor selection.
Related donors are required to receive the approval of an independent
committee in the hospital of transplant center whereas altruistic non-
related donors are referred to an independent national committee.
Potential donors can choose specic characteristics of the recipient
like a child, a mother of small children, a non-smoker or a member of
a specic religious group. But donors are not permitted to choose a
specic recipient [19,22,25].
Matnat chaim organization eects: e total number of live
kidney donation facilitated by Matnat Chaim since its founding in
February 2009 until the end of 2017 was 494. e mean age of these
kidney donors was 41 years (range between 23 and 66 years), 73% were
male and 27% were female. In 2011, only 27% of live donors were referred
by Matnat Chaim whereas by 2016 it has increased to 55% (Figure 1) [19].
rough Matnat Chaim organization, the number of deceased
donors had increased from a maximum of 87 until 2010 to 117 in
2013 and 115 in 2016. Also, the number of live kidney donor increased
from 78 in 2010 to 222 in 2016. Matnat Chaim facilitated 4 live donor
kidney transplantation in 2009, 11 in 2010, 32 in 2011, 37 in 2012, 33
in 2013, 49 in 2014, 89 in 2015, 127 in 2016 and 112 live donor kidney
transplants in 2017 [19].
e increase in the number of transplants has resulted in a plateau
in the number of patients on the transplant waiting list [19,22,27].
Iranian Model of Transplantation Model
e rst kidney transplant in Iran was done in 1967, it was the rst
organ transplant in the Middle East Society for Organ Transplantation.
In 1988, because of the long waiting list, the Iranian Ministry of
Health for kidney transplant, regulated living-unrelated donor kidney
transplant program was approved [28]. In addition, in 1989, a religious
approval (fatwa) from the Supreme Religious Leader was achieved that
recognized brain death and allowed deceased-donor organ transplant [29].
By 1999, the kidney transplant waiting list in Iran was eliminated.
Subsequently, transplant centers created performing deceased-donor
kidney, liver, and heart transplants [30].
Figure 1. Shows the Matnat Chaim facilitation of 4 live donor kidney transplantation in
2009, 11 in 2010, 32 in 2011, 37 in 2012, 33 in 2013, 49 in 2014, 89 in 2015, 127 in 2016
and 112 live donor kidney transplants in 2017
Issa Al Salmi (2020) Transplantation Model- Analytical Review: A Strategic Proposal and Moral Obligation
Volume 13: 4-7
Trends in Transplant, 2020 doi: 10.15761/TiT.1000281
In 2000, the Brain Death and Organ Transplantation Act was
approved by the Iranian parliament, legalizing deceased-donor organ
transplant. e transplant team at Shiraz began performing more
deceased-donor kidney and liver transplants and became a fruitful
deceased-donor organ transplant model in the country [28-31].
In 2011 and 2012, Iran was ahead of all country members of
the Middle East Society for Organ Transplantation in performing
deceased-donor kidney and liver transplants [31] and graded as
number 33 among the 50 most active countries worldwide.
By the end of 2012, there were 34166 kidney (including 4436
deceased-donor) and 2021 liver (including 1788 deceased-donor), 482
heart, 147 pancreas, 63 lungs, and several intestine and multi-organ
transplants performed in Iran.
Organ Transplantation in Iran before and aer 2008
Istanbul Declaration
In 1979, the period previous to the revolution, random transplanted
cases were done, but despite the high expenditures and cultural and
language barrier, most of the 114 transplantations performed in this
period, were carried out abroad, especially in the United Kingdom,
were using imported organs from Euro transplant organ sharing
network with large payment. e limited kidney transplantation
activities were totally stopped two years aer revolution and the
expertise transplantation surgeons le the country [32,33].
In 1984 and despite the grim circumstances, the rst kidney
transplantation aer a temporary stop, was carried out in Tehran with
minimal facilities and support, but excellent outcome [34]. e organ
was donated by a brother to his sister. Fiy such transplants, all from
live related donors, were carried out in various setups.
is eventually led to the expansion of the National plan for kidney
transplantation, which was ocially well-known in a hospital devoted
to nephrology and urology patients. e hospital was university-
aliated, and a multidisciplinary team was assigned to manage
and govern the program. e excellent success rate, low cost and
remarkable outcome encouraged all patients to join the waiting list for
transplantation [31,35-37].
To prevent transplant tourism, in 1992 the high council of organ
transplantation in the Ministry of Health and Medical Education ruled
the prevention of foreign nationals to be transplanted in Iran, except
they present a live donor of their own nationality. Since April 2010,
following Istan bul Declaration, and to respect its contents, kidney
transplantation of foreign individuals was entirely removed from
transplantation activities in Iran [37].
Despite the eorts to motivate and support deceased organ
donation, still the large gap between available donors and demand,
makes the unrelated donation an alternative. To support the donors
and recipients, a state-regulated system was started, and a recompense
was oered to the volunteer donors following the donation service.
ough this reward was satisfactory at the beginning, but year by year
it slowly lost its real worth due to rise each year and situ ation evolved
to present day, where the additional demand is compensated by the
recipients [38].
However, e Bio ethics Committee of the Academy of Medical
Sciences of IR Iran conrmed that the act of kidney donation from
living related and unrelated volunteers is generally acceptable,
and oering a re ward as appreciation, gi or compensation is not
considered unethical and should not discourage this honorable act
provided. Various strategies of Iranian model to solve the dilemma of
sale vs. donation is shown Table 1.
• Saving lives of many ESKD patients especially before the Brain
• Death Act
• Waiting list omission
• Complete medical and psychological examination of donors in the hospital, in addition to routine outpatient
evaluation process
• No middleman/broker or travel to the country to buy kidneys
• No financial benefit of transplantation team
• Development of BDD program and its progression (increasing experience of transplantation centers)
Legal approval of compensation for donor and transplantation expense in the hospital
• Donors cannot seek the highest possible price (no foreign patient can enter the system)
• Rich and poor can be transplanted
Same nationality of donor/recipient:
• Getting informed written consent from donor and next of kin
• No coercion of donors
• No exploitation of the poor
• Donor age 18
• Separation of scientific responsibilities from ethical ones
• Protection of fundamental doctor–patient relationship
Supervision of Patients’ Foundation on donor motivation:
• Decrease donor harm to the least
• Development of newer and safer approaches possible (e.g., laparoscopic nephrectomy)
• Complete medical and psychological examination
Transplantation centers in academic hospitals licensed by the MOHME:
• Direct financial connection between donor/recipient (negative point)
• Donors do not like to be known (negative point)
• Transparency of system (no abuse in the system)
• Development of BDD program and its progression (by redirection of the budget)
• Lack of protracted/long-term follow-up of donors
Supervision of Patients’ Foundation on donor motivation:
Table 1. Shows various strategies of the Iranian model to solve the dilemma of sale vs. donation
Issa Al Salmi (2020) Transplantation Model- Analytical Review: A Strategic Proposal and Moral Obligation
Volume 13: 5-7
Trends in Transplant, 2020 doi: 10.15761/TiT.1000281
Pakistan Model of Transplantation Model
Kidney transplantation in Pakistan begin in 1979 from living
related donors in public sector hospitals. e activity was as low as less
than 50 cases per year but slowly rose to more than 100 per year by the
mid-1990s [40].
Shortage of donors for lack of a de ceased donor program along
with rapidly developing skill in transplantation principal to unrelated
commercial trans plants in the private sector where the poor were
exploited to donate kidneys for US$ 1000 to 2000 [40,41].
By the year 2000, the number of transplants per year ex ceeded
1000—more than 70% of which were unrelated commercial donors [42].
Although, most of the recipients were local, which lead Pakistan
to become the largest center of transplant tourism by the year 2005—
where almost 1500 foreigners received transplants every year in private
sector hospitals [42].
By the year 2007, of 2500 trans plants performed annually in
Pakistan, 2000 were unrelated commercial transplants, 1500 of which
were for foreigners. Of the 500 living related transplants, 50% were
performed in one center in Karachi, southern Pakistan [42].
Dialysis and transplantation service were available for few select
people who could a ord it with >90% of population disfranchised
[40-42]. is situation made transplantation irrelevant to the com-
mon people and consequently for it to gain ground as a successful
management , it had to be made avail able to this population and
thereaer the soci ety could be asked to support transplantation,
declaration of law and organ donation from living and deceased [42].
A single institute in Karachi started a combined dialysis and
transplant program. In addition, all services were oered free of
charge to all patients to include recipient and donor follow-up and
post-transplant immunosuppressive drugs. is program was based
on a philoso phy of public-government partnerships with the public
donating up to 60%–70% and the government the rest [42-44].
Excellent results of the Institute established reliability overseas and
lead to the rst cadaver kidney transplant in Pakistan by the courtesy of
Euro-trans plant Foundation [42]. Aer transplantation of 26 deceased
do nor kidneys from Euro-transplant becomes the rst resident
deceased donor in 1998 followed by another in 2005.
e Transplant Law in Pakistan in 2010: e beak on
transplantation was accessible in the legislature almost 15 years ago
in the early 90s. It remained inactive for the rst decade in numerous
specialist committees from government to government mainly due to non-
acceptance of transplantation by the so ciety as a therapeutic modality
due to social, cultural and religious concerns [42]. is lack of facilities
in the presence of skill moved transplantation in the private sector largely
depended on living related donation. SIUT, however, established itself as
the best transplant institution in the country, started a campaign against
organ sale and transplant tourism [40,42,44].
Feature of the Transplant Ordinance in Pakistan: e transplant
rules excluded commercial unrelated transplantation of locals as well
as foreigners. It allowed donation only from living donors who are rst
degree relatives and legally related. But in case of unavailable of donor,
a “non-rst degree relative” can donate aer getting approval by an
assessment committee. In addition, the regulation permitted donation
from “brain death” donors who gave consent in life to be donors or
with the consent of their head of kin [40,42,44-46].
Finally, punishment for breaking the ordinance was 10 years
custody and a ne of U$ 15,000 [41,42].
Discussion
ere is no perfect system or model of transplantation worldwide.
However, the IR of Iran Transplantation Model seems the most suitable
model in the region and world-wide. Oman may need to adopt such a
model if to be successful in its provision of necessary transplantation
care for various end-stage organ failure. Treatment of patients with
ESKD is one of the major health care challenges in Oman, as the
number of ESKD patients is continuously increasing. e prevalence of
patients receiving RRT at the end of 2013 was 2382 with an incidence of
120 per million population, and it was more frequent in young patients,
as 86% of them were of 64 years and below. e prevalence and
incidence of treated ESKD patients reported in 2013 in dierent Asian
and Middle East countries with some similarities in the geographic and
socioeconomic patterns as in Oman. ese countries have prevalence
rates of treated ESKD patients ranging between 200 and 3000 patients
per million population. As well as an increase in ESKD prevalence,
as expected, a gradual increase in the outpatient morbidity caused by
CKD has been observed. In 2014, for example, a total of 1280 males and
3150 females per 100 000 population had evidence of kidney or urinary
tract disease. Additionally, surgical procedures related to the kidney
and urinary tract constitutes a considerable economic burden [1-3].
Transplant regulations were established in Oman in 1994 and were
supported by formal ministerial decision. e brain death criteria have
been accepted by civil authorities and religious authorities but have not
yet been accepted by the public at large, possibly due to poor educational
programs and media advertisements. As the deceased donor program
is still in its infancy, we anticipate that it will increase and hence curtail
the use of commercial transplantations. Implementing comprehensive
central strategies to consolidate the living related donor kidney
transplantation and supporting kidney organ donation is the way
forward in treating people with ESKD [3,4].
A survey was carried out in 2010 to evaluate the attitude of our
population toward organ transplantation and the results showed
great public acceptance of kidney donation during life and very low
acceptance of aer death donation. Religious and sociocultural
factors have to be further addressed and regulations and laws have to
be strengthened to further improve the service and to curtail organs
commercialism practices.
Although Oman deceased donor transplants program was among
the earlier programs in the Gulf region, it was not fully sustainable,
and the transplantation program turns now to be mainly living related
donor transplants program. e absence of resources to establish a
committed organizational unit for deceased donor transplants was the
major challenge causing its unsustainability compared to neighboring
countries. e program requires a good network of donors’ coordinators
throughout all intensive care units. Similarly, the absence of kidney
support societies is an important hurdle that the government must
tackle and to ease the establishment of such important public services
to further improve the care of people with ESKD. e disturbing eects
caused by unregulated commercial transplants performed outside the
country, which is called transplant tourism, contributed to some extent
to the unsustainability of this program. Interestingly, the support of the
Declaration of Istanbul, in which the ethical guidelines and framework
for transplantation was established, had led to immediate decrease
in commercial transplants and a noticed increase in the number of
transplants performed in Oman during the period of 2007 to 2009
Issa Al Salmi (2020) Transplantation Model- Analytical Review: A Strategic Proposal and Moral Obligation
Volume 13: 6-7
Trends in Transplant, 2020 doi: 10.15761/TiT.1000281
(from 12 to 23 operations) [3,4]. However, in recent years, there is an
increasing trend towards commercial transplantation, especially from
Pakistan and China, as well as countries that suer from political unrest
and natural disasters, where the poor being targeted for their organs in
exchange for a nancial gain.
Previously, we reported that Oman has exclusively a living-related
kidney transplant donation program, but this program contributes
22.7% of the kidney transplantations for all the ESKD patients living
with a kidney transplant. is has been the result of commercial
transplantation from various developing countries. Deceased donor
programs contributed to only 1.3% of total transplanted cases in
Oman [3]. However, 76% of kidney transplant cases are commercial
transplantations that are being done abroad. A recent paper found
that 3% of their participants paid only $15,000 to $30,000, 33% paid
between $30,000 and 45,000, and 52% of the participants stated that
they had paid more than $45,000 for KT; 65% of them had paid before
the operation and aer the agreement was made with the broker on the
price for the obtained kidney [4].
e brain death concept is still distant in the Omani public. e
meaning is that an individual is dead, according to medical denition,
while the heart is still beating causing a lot of confusion between the
patient’s career and the caring doctor. is misunderstanding of the
concept of brain death avoids the use of these individuals as potential
organ donors, which is a problem in an era where the needs for organs
exceeds their availability.
In Oman, despite the permission from religious and legal
authorities to use organs from deceased donors we are now practicing
almost solely with living related donors. e public attitude toward
donation is essential in all transplantation programs. Furthermore, a
survey was carried out in 2010 to assess Omani populations’ attitude
towards organ transplantation, showed great public acceptance of
kidney donation during life and very low acceptance of aer death
donation. However, religious and sociocultural factors have to be
further investigated and regulations and laws have to be strengthened
to further expand the facility and to prohibit organs commercialism
action [4].
A common thread that binds all faiths of the world is that the
saving of life overrides all objections, and no religion is against organ
donation. In KSA and Kuwait, have successful kidney transplantation
programs, which might notify the kidney transplantation program
in Oman to assume some variations to the present system to make
the program more active. However, the MOH has provided all the
resources for successful kidney transplantation program in Oman such
as the transplant coordination unit and kidney donor clinic [1,3-5].
Oman, similar to countries in the regions, and various other
countries around the world must empower their citizens, provide the
care required to improve their lives, and preserve dignity and human
values. Eorts must therefore be directed towards strengthening the
national program with full logistic, nancial, and strong legislation to
protect human lives locally, regionally, and globally and must collaborate
with international eorts to combat organ tracking and commercialism
and to encourage the notion of humanity’s best interest [3,4].
ough Oman deceased donor transplants program was among the
earlier programs in the Gulf region, it was not fully supportable, and the
transplantation program turns now to be mainly living related donor
transplants program. e major challenge causing the unsuitability of
this program in Oman compared to the neighboring countries was the
absence of resources. e brain death criteria have been accepted by
civil authorities and religious authorities but have not yet accepted by
the public at large, possibly due to poor awareness programs and media
announcements [3,4].
A clear guideline related to the diagnosis of brain death and
subsequently guidelines related to the withdrawal of life support
in these patients and been approved by the primary health services.
However, we as health care professionals and physicians have failed
to bridge the gap that exists between medical knowledge, legality of
brain death, religious views, and the education of our community in
this regard [3,4].
In order to resolve this, dierent institutions, most importantly
RH and SQUH, across the country need to come together to form a
committee in order to deal with this important and critical subject.
Secondly, we need to arrange and conduct a forum, including religious
and legal authorities, to discuss organ donation and come to a
consensus on policies and guidelines relating to the process of organ
donation. Finally, we also need to educate the public on sensitive issues
such as this and increase their overall awareness of brain death as a
medical condition. Religion plays an important part in the public live
of the population and hence a proactive religious approach is needed
at a regular pace to inform our citizens especially during the Friday
prayers where thousands of people attend it on a weekly basis. Media
must do a similar task as well to better approach young people and
educate them of the importance of organ donation.
In Oman, the decision to donate organs is a crucial step in the
process of transplantation. Moreover, Arab countries have poor
transplant rates because of multi factors. Which might include, have
low levels of infrastructure, an inadequate trained professional sta lack
of a legal structure leading the brain death program, religious, cultural
and social constraints, patient anxiety, physician bias, commercial
encouragements that favor dialysis and geographical remoteness. It is
based on personal or familial opinions that are strongly inuence by
many factors, including education, socioeconomic status, religion and
cultural characteristics [3,4].
Al Alawi, et al. stated that the DD program needs a good network
of donors’ coordinators all over intensive care units [1,2]. In the same
way, the absence of kidney association support is an important obstacle
that the government must challenge and to comfort the launch of such
important public services to improve the care of people with [1,3,4].
In addition to deceased program, Oman will need a few parallel
strategies for a successful organ transplantation, the full support of live
organ transplantation, both related and non-related. ese pathways
require logistic and nancial support of both government and NGO.
Presently, Oman uses, through its patients, other countries citizens
to provide organ, i.e. commercial transplantation. is need to stop!
Legally and ethically, it is unacceptable to continue with such an act in
the twenty rst century. If at all, there is a need to utilize live unrelated,
then it must stay within the country and no need to cross borders to
other countries. Morally, if there is a need for live unrelated, then every
country could provide some strategy to have a fair and acceptable
system within the community to enable such a strategy. Any citizen
individual willing to be live unrelated kidney donor would be registered
in a general donor pool and may avail for a nancial compensation of
15,000-20,000 OMR. In addition, the donor is also would be provided
with follow up medical care for the rest of his live. e donation cannot
be specied to individual, but it would be in a general pool of donor.
is would ensure a fair and equitable system where the general criteria
Issa Al Salmi (2020) Transplantation Model- Analytical Review: A Strategic Proposal and Moral Obligation
Volume 13: 7-7
Trends in Transplant, 2020 doi: 10.15761/TiT.1000281
Copyright: ©2020 Issa Al Salmi. This is an open-access article distributed
under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the
original author and source are credited.
for recipient is utilized in this pool. Recipient need to wait for at least a
year to avail for such a service.
Hence, these three major strategies, deceased, living related and
living unrelated, would be able to overcome shortage of organs (kidney)
in the country. Importantly, it would curtail the transplant tourism and
ameliorate all the suering of its endeavor. However, only time and
experience shall prove its success or failure [1,3,4].
References
1. Al Alawi I, Al Salmi I, Al Mawali A, Al Maimani Y, Sayer JA (2017) End-Stage Kidney
Failure in Oman: An Analysis of Registry Data with an Emphasis on Congenital and
Inherited Renal Diseases. Int J Nephrol 2017: 6403985. [Crossref]
2. Al Alawi IH, Al Salmi I, Al Mawali A, Sayer JA (2017) Kidney Disease in Oman: a
View of the Current and Future Landscapes. Iran J Kidney Dis 11: 263-270.
3. Al Ismaili F, Al Salmi I, Al Maimani Y, Metry AM, Al Marhoobi H, et al. (2017)
Epidemiological Transition of End-Stage Kidney Disease in Oman. Kidney Int Rep 2:
27-35. [Crossref]
4. Al Rahbi F, Al Salmi I (2017) Commercial Kidney Transplantation: Attitude, Knowledge,
Perception, and Experience of Recipients. Kidney Int Rep 2: 626-33. [Crossref]
5. Al Salmi I, Metry AM, Al Ismaili F, Hola A, Al Riyami M, et al. (2018) Transplant
tourism and invasive fungal infection. Int J Infect Dis 69: 120-129. [Crossref]
6. Al-Sayyari A (2017) The story of the rst deceased donor kidney donation in Saudi
Arabia – by a rsthand witness. Saudi J Kidney Dis Transpl 28: 983-991. [Crossref]
7. Al-Khudair WK, Huraib SO (1996) Kidney transplantation in Saudi Arabia: a unique
experience. World J Urol 14: 268-271. [Crossref]
8. Shaheen FA, Souqiyyeh MZ, Attar MB, al-Swailem AR (1996) The Saudi Center for
Organ Transplantation: an ideal model for Arabic countries to improve treatment of
end-stage organ failure. Transplant Proc 28: 247-249. [Crossref]
9. Shaheen FA, Souqiyyeh MZ (2004) How to improve organ donation in the MESOT
countries. Ann Transplant 9: 19-21. [Crossref]
10. Shaheen FA, Souqiyyeh MZ (2004) Increasing organ donation rates from Muslim
donors: lessons from a successful model. Transplant Proc 36: 1878-1880. [Crossref]
11. Guy-Frank CJ, Persaud K, Butsenko D, Jindal RM, Guy SR (2019) Developing
a Sustainable Renal Transplant Program in Low- and Middle-Income Countries:
Outcome, Challenges, and Solutions. World J Surg 43: 2658-2665.
12. Schnitzler MA, Whiting JF, Brennan DC, Lin G, Chapman W, et al. (2003) The
expanded criteria donor dilemma in cadaveric renal transplantation. Transplantation
75: 1940-1945. [Crossref]
13. Whiting JF, Kiberd B, Kalo Z, Keown P, Roels L, et al. (2004) Cost-eectiveness of
organ donation: evaluating investment into donor action and other donor initiatives. Am
J Transplant 4: 569-573. [Crossref]
14. O’Connor KJ, Delmonico FL (2005) Increasing the Supply of Kidneys for
Transplantation. Seminars in Dialysis 18: 460-462.
15. Wiesner RH (2005) Patient selection in an era of donor liver shortage: current US
policy. Nat Clin Pract Gastroenterol Hepatol 2: 24-30. [Crossref]
16. Akkina SK, Asrani SK, Peng Y, Stock P, Kim WR, et al. (2012) Development of organ-
specic donor risk indices. Liver Transpl 18: 395-404. [Crossref]
17. Lee CM, Scandling JD, Shen GK, Salvatierra O, Dafoe DC, et al. (1996) THE
KIDNEYS THAT NOBODY WANTED: Support for the Utilization of Expanded
Criteria Donors1. Transplantation 62: 1832-1841. [Crossref]
18. Johnson LB, Kuo PC, Schweitzer EJ, Ratner LE, Klassen DK, et al. (1996) Double
renal allografts successfully increase utilization of kidneys from older donors within
a single organ procurement organization. Transplantation 62: 1581-1583. [Crossref]
19. Wasser WG, Boner G, Koslowsky M, Lazar A (2018) Emergence of an Israel faith-
based community organization facilitating live donor kidney transplantation. BMC
Nephrology 19: 128. [Crossref]
20. No authors (2008) The Declaration of Istanbul on Organ Tracking and Transplant
Tourism. Clin J Am Soc Nephrol 3: 1227. [Crossref]
21. Quigley M, Wright L, Ravitsky V (2012) Organ Donation and Priority Points in Israel:
An Ethical Analysis. Transplantation 93: 970-973. [Crossref]
22. Berzon C (2018) Israel’s 2008 Organ Transplant Law: continued ethical challenges to
the priority points model. Isr J Health Policy Res 7: 11. [Crossref]
23. Lavee J, Ashkenazi T, Gurman G, Steinberg D (2010) A new law for allocation of donor
organs in Israel. Lancet 375: 1131-1133. [Crossref]
24. Cohen J, Ashkenazi T, Katvan E, Singer P (2012) Brain death determination in Israel:
the rst two years experience following changes to the brain death law-opportunities
and challenges. Am J Transplant 12: 2514-2518. [Crossref]
25. Jotkowitz A (2008) Notes on the new Israeli organ donation law-2008. Transplant Proc
40: 3297-3298. [Crossref]
26. Gruenbaum BF, Jotkowitz A (2010) The practical, moral, and ethical considerations of
the new Israeli law for the allocation of donor organs. Transplant Proc 42: 4475-4478.
[Crossref]
27. Lavee J, Ashkenazi T, Stoler A, Cohen J, Beyar R (2013) Preliminary marked increase
in the national organ donation rate in Israel following implementation of a new organ
transplantation law. Am J Transplant 13: 780-785. [Crossref]
28. Ghods AJ (2002) Renal transplantation in Iran. Nephrol Dial Transplant 17: 222-228.
[Crossref]
29. Ghods A (2007) Organ Transplantation in Iran. Saudi J Kidney Dis Transpl 18: 648-
655. [Crossref]
30. Ghods AJ, Savaj S (2006) Iranian Model of Paid and Regulated Living-Unrelated
Kidney Donation. Clin J Am Soc Nephrol 1: 1136. [Crossref]
31. Ghods AJ (2014) The history of organ donation and transplantation in Iran. Exp Clin
Transplant 12 Suppl 1: 38-41. [Crossref]
32. Haghighi AN, Ghahramani N (2006) Living unrelated kidney donor transplantation in
Iran. Nat Clin Pract Nephrol 2: E1. [Crossref]
33. Malakoutian T, Hakemi MS, Nassiri AA, Rambod M, Haghighi AN, et al. (2007)
Socioeconomic status of Iranian living unrelated kidney donors: a multicenter study.
Transplant Proc 39: 824-825. [Crossref]
34. Ghods AJ, Ossareh S, Savaj S (2003) Results of renal transplantation of the Hashemi
Nejad Kidney Hospital--Tehran. Clin Transpl 2000: 203-210. [Crossref]
35. Einollahi B (2004) Iranian experience with the non-related renal transplantation. Saudi
J Kidney Dis Transpl 15: 421-428. [Crossref]
36. Fazel I (1995) Renal transplantation from living related and unrelated donors.
Transplant Proc 27: 2586-2587. [Crossref]
37. Mahdavi-Mazdeh M (2012) The Iranian model of living renal transplantation. Kidney
International 8: 627-634. [Crossref]
38. Nobakht Haghighi A, Broumand B, Fazel I (2011) Organ Transplantation in Iran before
and after Istanbul Declaration, 2008. Int J Organ Transplant Med 2: 1-3. [Crossref]
39. Abbaszadeh S, Nourbala M, Taheri S, Ashraf A, Einollahi B (2008) Renal
Transplantation from Deceased Donors in Iran. Saudi J Kidney Dis Transpl 19: 664-
668. [Crossref]
40. Rizvi SA, Naqvi SA, Zafar MN, Hussain Z, Hashmi A, et al. (2010) Living related renal
transplants with lifelong follow-up. A model for the developing world. Clin Nephrol 74
Suppl 1: S142-S149. [Crossref]
41. Rizvi SA, Naqvi SA, Zafar MN, Hussain Z, Hashmi A, et al. (2011) A renal
transplantation model for developing countries. Am J Transplant 11: 2302-2307.
[Crossref]
42. Rizvi SAH, Anwar Naqvi SA, Zafar MN, Hussain Z, Hashmi A, et al. (2010) Pakistan
abolishes kidney market and ushers in a new era of ethical transplantation. Int J Organ
Transplant Med 1: 193-197. [Crossref]
43. Rizvi AH, Naqvi AS, Zafar NM, Ahmed E (2009) Regulated compensated donation in
Pakistan and Iran. Curr Opin Organ Transplant 14: 124-128. [Crossref]
44. Rizvi SA, Naqvi SA, Zafar MN, Akhtar SF. A kidney transplantation model in a low-
resource country: an experience from Pakistan. Kidney Int Suppl 3: 236-240. [Crossref]
45. Rizvi S, Anwar Naqvi S (1996) Renal Replacement Therapy in Pakistan. Saudi J
Kidney Dis Transpl 7: 404-408.
46. Rizvi SA, Sultan S, Zafar MN, Naqvi SA, Lanewala AA, et al. (2013) Pediatric kidney
transplantation in the developing world: challenges and solutions. Am J Transplant 13:
2441-2449. [Crossref]
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
Background: The 2014 Consensus Conference on Best Practices in Living Kidney Donations recognized live donor kidney transplantation as the best treatment for late-stage kidney disease, yielding superior graft and patient survival, improved quality of life, fewer requirements for dialysis and increased cost-effectiveness compared to deceased donor kidney transplantation. Yet in spite of the excellent results of living kidney donation, the annual number of living kidney donors is declining in many countries, including the United States. In Israel, a non-profit organization, Matnat Chaim ("Gift of Life" in Hebrew), a faith-based initiative, has emerged as a major force for arranging living donor kidney transplantation mainly by facilitating altruistic living unrelated donor transplantation. Methods: A retrospective review of the records of live kidney donations facilitated by the Matnat Chaim organization and referred to Israel transplant centers, since the organization's inception in 2009, was performed and compared to published data from the Israel Ministry of Health. Results: Matnat Chaim has facilitated 494 live kidney donations since its founding in February 2009 until the end of 2017. Of the 124 live kidney transplants performed in 2016, 111 (90%) were shown to be altruistic and unrelated. This large number of donations was associated with a doubling of the total number of kidney transplantations, performed in Israel (data published by the Israel Ministry of Health). Conclusions: The success of an Israel community organization in the promotion of kidney transplantation may serve as a model for other religious and non-religious communities worldwide.
Article
Full-text available
In 2008, responding to a widening gap between need and availability of transplant organs, Israel’s Ministry of Health adopted a program of incentivized cadaveric organ donation. The Organ Transplant Law rewards individuals with prioritized access to organs on the condition that they participate in procurement efforts. Priority is awarded in the form of additional points allocated to the individual’s organ recipient profile. Although Israel has experienced moderate gains in the years since the law’s implementation, these have not been sufficient to satisfy the demand. Furthermore, the law faces logistical and ethical challenges. These challenges could potentially be resolved by shifting the organ procurement default to routine retrieval rather than the current default of presumed refusal to organ retrieval. This paper examines philosophical and practical challenges to the priority points policy and weighs whether Israel should consider an alternative policy of routine retrieval of transplant organs with the option to opt out of the donor pool.
Article
Full-text available
Background: Deceased and live-related renal transplants (RTXs) are widespread approved methods throughout the world. In addition, commercial RTX has become popular in certain places driven by financial greed. Method: This is a retrospective, descriptive study was done at the Royal Hospital (RH) from 2013 to 2015. The data have been collected from the national Oman kidney transplant registry. All transplant cases retrieved were divided into two groups, Live-related-RTX performed in Oman and commercial-unrelated-RTX performed abroad. Furthermore these groups were divided into those without and those with evidence of fungal infection either in the wound or renal graft. Results: There were 198 cases of RTX, of whom 162 (81.8%) had commercial RTX that were done abroad. In 8% of patients who had commercial RTX, IFIs were diagnosed; of these, 76.9% underwent nephrectomy and 23.1% continued with a functioning graft. None of the RTXs performed in RH contracted IFIs. The most common fungal isolates were Aspergillus species including A Flavus, A. Fumigatus, A. Nidulans and A. Nigrican) followed by Zygomycetes. However, there was no evidence of fungal infection including Aspergillus outside the graft site. Computerized tomography (CT) findings showed infarction of graft, renal artery thrombosis, aneurysmal dilatation of external iliac artery, fungal ball or just presence of peri-graft collection. Of the total IFIs, 23.1% died due to septic shock and 53.8% were alive on hemodialysis. The remaining 23.1% who did not undergo nephrectomy demonstrated acceptable graft function. Conclusion: This is the largest single center study in commercial RTX reporting the highest number of patients with IFI acquired over a relatively short period of time. Aspergillus spps were the main culprit fungi with no Candida spps being isolated. A high index of suspicion might be the most reasonable mean to reduce the possible grim outcome. Improving legal transplant programs and strengthening the legal laws can prevent commercial transplant tourism.
Article
Full-text available
Oman is located in the southeast of Arabian Peninsula with a relatively young population of about 3 831 553 people. The Ministry of Health, which is the healthcare provider, is facing a challenge with the increased levels of noncommunicable diseases including chronic kidney disease. A growing number of patients progress to end-stage kidney disease (ESKD), demanding renal replacement therapy. In 2014, there were 1339 of ESKD patients receiving dialysis and almost 1400 patients received kidney transplants. The estimated annual incidence of ESKD is 120 patients per million population. Diabetes mellitus and hypertensive nephropathy are the commonly identified causes of ESKD. Many patients with glomerulonephritis, systemic lupus erythematosus, nephrolithiasis, and inherited kidney disease present with advanced chronic kidney disease. This article reviews the current status of kidney disease in Oman and addresses the present and future needs, through a systematic-review of all related papers.
Article
Full-text available
Globally, end-stage kidney disease (ESKD) is a huge burden on health care systems. The aims of this study were to perform a comprehensive epidemiological and etiological report of ESKD patients commencing RRT in Oman with an emphasis on genetic causes and inherited kidney disease. All newly registered Omani patients with ESKD commencing RRT from 2001 until 2015 ( n=2 ,922) were analysed using the RRT register in Oman. All potentially genetic or inherited causes of ESKD were reviewed. In Oman, ESKD is more prevalent in males (57.1%) than females (42.9%) with a median age of incident ESKD of 53 years. Diabetic nephropathy was the most prevalent cause of ESKD (46%), followed by hypertensive nephropathy (19%), glomerulonephritis (15%), and inherited kidney disease (5%). For patients less than 20 years of age inherited kidney disease accounted for 32.5% of cases. Of this cohort with inherited renal disease, 40.3% had autosomal dominant polycystic kidney disease, 11.5% had congenital anomalies of the kidney and urinary tract, 9.4% had Alport syndrome, and 7.2% had autosomal recessive polycystic kidney disease. This study represents a comprehensive population-based epidemiological and etiological report of ESKD patients in Oman commencing RRT. Inherited kidney disease was the leading cause of paediatric ESKD.
Article
Full-text available
Background and objectives: Kidney transplantation is the gold standard for patients with end- stage kidney disease (ESKD). In view of shortages of available organs, long wait times for possible transplantation and strict regulation, many patients opt for commercial transplantation. This study elicits the reasons and motivations for ESKD patients to elect for commercial transplant. Design, setting, participants & measurements: A questionnaire-based evaluation was conducted during the period from July 2015 until late December 2015. It consisted of 29 multiple choice questions and was distributed to all patients who underwent commercial kidney transplantation. Results: One hundred fifty patients were approached to participate and 106 agreed to participate. Of the participants, 60% were male with an average age of 41.5(SD14.8) and ranged from 18 to 83 years. The majority (82%) of our participants were educated ranging from primary to college level. The major reason (71%) for these participants to obtain commercial transplants was stated as the unavailability of a live related donor. 13% stated that they objected to get a kidney donated from a family member and 9% stated they were worried to take a kidney from a family member. Finally, 3% of participants stated that they needed prompt transplant and could not wait for a long time for transplant investigations and the workup associated with this program. Conclusions: The study showed that the most common underlying cause for seeking commercial transplantation is the unavailability of a national transplant program, particularly transplantation from deceased sources. All western ethical arguments turn out to become of vital importance in developing countries, because transplantation is the cheapest renal replacement therapy.
Article
Full-text available
The number of persons receiving renal replacement therapy (RRT) is estimated at more than 2.5 million worldwide, and is growing by 8% annually. Registries in the developing world are not up to standards compared to the United States Renal Data System (USRDS). Herein we examine the causes, progression, and magnitude of end-stage kidney disease (ESKD) over 3 decades in Oman. Methods: We examined ESKD data from 1983 to 2013. Data from 1998 to 2013 were obtained through an Information Management System. Data before 2008 were collected from patients’ files. A questionnaire based on USRDS form 2728 was completed by nephrologists once a citizen reached ESKD. Results: A total of 4066 forms were completed, with a response rate of 90% (52% male). The mean (SD) age was 50.1 (14.0) years. By 31 December 2013, there were 2386 patients alive on RRT, of whom 1206 were on hemodialysis (50.5%), 1080 were living with a functioning kidney transplant (45.3%), and 100 were receiving peritoneal dialysis (4.2%). The incidence of ESKD on RRT was 21, 75, and 120 per million population in 1983, 2001, and 2013, respectively. Similarly, the prevalence of ESKD was 49, 916, and 2386 in 1983, 2001, and 2013 respectively. Among patients with ESKD on RRT, a progressive rise was seen in diabetic nephropathy, with 5.8%, 32.1%, and 46% in 1983, 2001, and 2013 respectively. Discussion: The incidence and prevalence of ESKD has increased progressively over last 30 years. This is anticipated to continue at an even higher rate in view of the progressive rise in noncommunicable diseases. Continuous improvement in registries is required to improve capturing of ESKD patients for providing accurate data to health authorities, and enhancing public awareness of the magnitude, future trends, treatments, and outcomes regarding ESKD.
Article
Full-text available
Pakistan is a low-resource country with a population of 185 million where expenditure on health is 1.3% of the gross national product. The estimated incidence of end-stage renal disease (ESRD) is 100 per million of the population. The paucity and high costs of renal replacement therapy render more than 90% of the ESRD population disenfranchised from replacement therapy. Our center, which is a government sector organization, established as an integrated dialysis and living related renal transplant program in the 1980s, where all services were provided free of cost to all patients with life-long follow-up care including medications. The model was based on a concept of community/government partnership where the contributions to funds vary between 40% and 60% for each partner. The model has been self sustaining for 25 years, with an annual budget of $28 million in 2010. Presently, over 600 patients are dialyzed each day and each week, 7–10 patients have received live related transplants. The overall 1- and 5-year graft survival rate of 3150 transplants is 92% and 85%, respectively. Free dialysis and transplantation established our institute as a focus of transplantation in the country. This model therefore allowed the institute to have a vital role in the campaign against transplant tourism and in the promulgation of the transplant law. It shows that in low-resource countries, specialized centers in the government sector can, with community support, provide high-quality ESRD care to the disenfranchised population.
Article
Introduction The initiation of a kidney transplant program, in a low- and middle-income country, while striving to maintain excellent outcomes and adhere to high ethical, legal standards, is a formidable task. Herein, we review the outcomes and challenges of a living donor kidney transplant program from its inception to sustainability, in Guyana, South America. Methods This is a retrospective review of a living donor kidney transplant program instituted in Guyana in 2008. Data included recipient and donor demographics, cause of renal failure, donor–recipient matching and relationship, perioperative complications, timing and cause of death, graft failure, surgical technique, and laterality of organ procured. Patient and donor data were compared by phases and additionally compared to United States Renal Data Base System. Survival outcomes were compared by phases and by Kaplan–Meier curves. Results To date, 45 kidney transplants have been completed. Phase I (2007–2008) was the initiation of the program, which was comprised of upgrading hospital and operating rooms, obtaining antirejection medications, educating local providers, fostering a relationship with the government, and screening patients and living donors. We also began vascular access and peritoneal dialysis in the country, as well as introduced the companion public health service initiative: the SEVAK program. Phase II (2008–2014) involved completion of 25 living donor kidney transplants, of which there have been 11 confirmed deaths and 10 lost to follow-up. In Phase III (2015–present), 20 transplants have been completed to date, of whom only 1 died and none were lost to follow-up. In the third phase, we also introduced corneal transplantation to Guyana and have performed over 100 transplants. Conclusion Kidney transplantation can be safely and ethically performed in a low- and middle-income country. We applied lessons learnt from the first two phases to improve follow-up by appointing a local coordinator who goes to patient’s homes in remote villages. Currently, there is a stable local team that is performing transplants and following the patients. We believe that our model of public–private partnership can sustain kidney, as well as corneal, transplantation and could be replicated in other countries.
Article
The first kidney transplant in Iran was performed in 1967, and this was the first organ transplant in countries that are current members of the Middle East Society for Organ Transplantation. In 1988, in response to the long waiting list at the Iranian Ministry of Health for kidney transplant, a state-regulated living-unrelated donor kidney transplant program was adopted. By 1999, the kidney transplant waiting list in Iran was eliminated. In 1989, a fatwa (religious approval) from the Supreme Religious Leader was obtained that recognized brain death and allowed deceased-donor organ transplant. Subsequently, transplant centers began performing deceased-donor kidney, liver, and heart transplants. In 2000, the Brain Death and Organ Transplantation Act was passed by the Iranian parliament, legalizing deceased-donor organ transplant. The transplant team at Shiraz began performing more deceased-donor kidney and liver transplants and became a successful deceased-donor organ transplant model in the country. By the end of 2012, there were 34166 kidney (including 4436 deceased-donor) and 2021 liver (including 1788 deceased-donor), 482 heart, 147 pancreas, 63 lung, and several intestine and multiorgan transplants performed in Iran. In 2011, there were 2771 solid-organ transplants performed in Iran (37 transplants per million population), and Iran ranked as number 33 among the 50 most active countries worldwide. In 2011 and 2012, Iran was ahead of all country members of the Middle East Society for Organ Transplantation in performing deceased-donor kidney and liver transplants.